Corrigendum to “Precision medicine in ALK rearranged NSCLC: A rapidly evolving scenario” [Crit. Rev. Oncol./Hematol. 122 (February) (2018) 150–156]

The authors regret that there was a typographical error in text when the paper was published. The article mentions a 1603 EORTC trial but this should have read as 1613 EORTC trial.

Source: Critical Reviews in Oncology Hematology - November 2, 2018 Category: Cancer & Oncology Authors: Alfredo Addeo, Fabrizio Tabb ò, Tim Robinson, Lucio Buffoni, Silvia Novello Source Type: research